Literature DB >> 17706165

Therapy-related acute myelogenous leukemia and myelodysplastic syndrome.

Gautam Borthakur1, And Elihu E Estey.   

Abstract

Therapy-related acute myelogenous leukemia and myelodysplastic syndrome (t-AML/MDS) are increasing in prevalence with aging of the population and improved survival of patients treated with chemotherapy or radiotherapy for other malignancies. Research focused on the pathogenesis of t-AML/MDS will provide insight into the pathogenesis of de novo AML/MDS. Participation in clinical trials should be encouraged for this patient population because results with available treatment options are clearly suboptimal.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17706165     DOI： 10.1007/s11912-007-0050-z

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  46 in total

1.  Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.

Authors:  Georg Lenz; Martin Dreyling; Eva Schiegnitz; Torsten Haferlach; Joerg Hasford; Michael Unterhalt; Wolfgang Hiddemann
Journal:  J Clin Oncol       Date:  2004-12-15       Impact factor: 44.544

2.  Multiple myeloma and acute myelomonocytic leukemia.

Authors:  R A Kyle; R V Pierre; E D Bayrd
Journal:  N Engl J Med       Date:  1970-11-19       Impact factor: 91.245

Review 3.  Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?

Authors:  C R Hake; T A Graubert; T S Fenske
Journal:  Bone Marrow Transplant       Date:  2006-12-04       Impact factor: 5.483

4.  Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease.

Authors:  J Pedersen-Bjergaard; S O Larsen
Journal:  N Engl J Med       Date:  1982-10-14       Impact factor: 91.245

5.  DNA topoisomerase II in therapy-related acute promyelocytic leukemia.

Authors:  Anita R Mistry; Carolyn A Felix; Ryan J Whitmarsh; Annabel Mason; Andreas Reiter; Bruno Cassinat; Anne Parry; Christoph Walz; Joseph L Wiemels; Mark R Segal; Lionel Adès; Ian A Blair; Neil Osheroff; Andrew J Peniket; Marina Lafage-Pochitaloff; Nicholas C P Cross; Christine Chomienne; Ellen Solomon; Pierre Fenaux; David Grimwade
Journal:  N Engl J Med       Date:  2005-04-14       Impact factor: 91.245

6.  Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents.

Authors:  M K Andersen; D H Christiansen; M Kirchhoff; J Pedersen-Bjergaard
Journal:  Genes Chromosomes Cancer       Date:  2001-05       Impact factor: 5.006

7.  High incidence of myelodysplasia and secondary leukaemia in the UK Medical Research Council Pilot of autografting in chronic lymphocytic leukaemia.

Authors:  Donald W Milligan; Geothy Kochethu; Claire Dearden; Estella Matutes; Christopher MacConkey; Daniel Catovsky
Journal:  Br J Haematol       Date:  2006-04       Impact factor: 6.998

8.  ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.

Authors:  J Wang; T Hoshino; R L Redner; S Kajigaya; J M Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 9.  Targeting aberrant transcriptional repression in acute myeloid leukemia.

Authors:  Gerd H Moe-Behrens; Pier Paolo Pandolfi
Journal:  Rev Clin Exp Hematol       Date:  2003-06

Review 10.  Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities.

Authors:  J Pedersen-Bjergaard; D H Christiansen; M K Andersen; F Skovby
Journal:  Leukemia       Date:  2002-11       Impact factor: 11.528
View more
  11 in total

1.  Therapy-related acute myeloid leukemia in patients with lymphoma: A report of four cases and review of the literature.

Authors:  Dan Yang; Xiaorui Fu; Xudong Zhang; Wencai Li; Mingzhi Zhang
Journal:  Oncol Lett       Date:  2015-09-15       Impact factor: 2.967

2.  Long-term follow-up of therapy-related myelodysplasia and AML patients treated with allogeneic hematopoietic cell transplantation.

Authors:  J Finke; C Schmoor; H Bertz; R Marks; R Wäsch; R Zeiser; B Hackanson
Journal:  Bone Marrow Transplant       Date:  2016-01-11       Impact factor: 5.483

Review 3.  Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.

Authors:  Theo de Witte; David Bowen; Marie Robin; Luca Malcovati; Dietger Niederwieser; Ibrahim Yakoub-Agha; Ghulam J Mufti; Pierre Fenaux; Guillermo Sanz; Rodrigo Martino; Emilio Paolo Alessandrino; Francesco Onida; Argiris Symeonidis; Jakob Passweg; Guido Kobbe; Arnold Ganser; Uwe Platzbecker; Jürgen Finke; Michel van Gelder; Arjan A van de Loosdrecht; Per Ljungman; Reinhard Stauder; Liisa Volin; H Joachim Deeg; Corey Cutler; Wael Saber; Richard Champlin; Sergio Giralt; Claudio Anasetti; Nicolaus Kröger
Journal:  Blood       Date:  2017-01-17       Impact factor: 22.113

4.  Therapy-related myelofibrosis does not appear to exist.

Authors:  Lucia Masarova; Gabriele Todisco; Taghi Manshouri; Kate J Newberry; Jorge E Cortes; Hagop M Kantarjian; Zeev Estrov; Srdan Verstovsek
Journal:  Blood Adv       Date:  2017-05-26

5.  Chronic myeloid leukemia among patients with a history of prior malignancies: A tale of dual survivorship.

Authors:  Paul B Koller; Hagop M Kantarjian; Graciela M Nogueras-Gonzalez; Elias Jabbour; Srdan Verstovsek; Gautam Borthakur; Zeev Estrov; William G Wierda; Guillermo Garcia-Manero; Alessandra Ferrajoli; Farhad Ravandi; Susan M O'Brien; Jorge E Cortes
Journal:  Cancer       Date:  2016-10-20       Impact factor: 6.860

6.  Clinical and pathologic features of secondary acute promyelocytic leukemia.

Authors:  Amy S Duffield; Joseph Aoki; Mark Levis; Kathleen Cowan; Christopher D Gocke; Kathleen H Burns; Michael J Borowitz; Milena Vuica-Ross
Journal:  Am J Clin Pathol       Date:  2012-03       Impact factor: 2.493

Review 7.  Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Acute Leukemia.

Authors:  Ram Vasudevan Nampoothiri; Auro Viswabandya
Journal:  Indian J Hematol Blood Transfus       Date:  2020-08-12       Impact factor: 0.915

8.  Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility.

Authors:  Jeffrey A Knight; Andrew D Skol; Abhijit Shinde; Darcie Hastings; Richard A Walgren; Jin Shao; Thelma R Tennant; Mekhala Banerjee; James M Allan; Michelle M Le Beau; Richard A Larson; Timothy A Graubert; Nancy J Cox; Kenan Onel
Journal:  Blood       Date:  2009-03-18       Impact factor: 22.113

9.  Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia.

Authors:  Koji Sasaki; Elias Jabbour; Jorge Cortes; Tapan Kadia; Guillermo Garcia-Manero; Gautam Borthakur; Preetesh Jain; Sherry Pierce; Naval Daver; Koichi Takahashi; Susan O'Brien; Hagop Kantarjian; Farhad Ravandi
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-08-10

10.  Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.

Authors:  Mark R Litzow; Sergey Tarima; Waleska S Pérez; Brian J Bolwell; Mitchell S Cairo; Bruce M Camitta; Corey S Cutler; Marcos de Lima; John F Dipersio; Robert Peter Gale; Armand Keating; Hillard M Lazarus; Selina Luger; David I Marks; Richard T Maziarz; Philip L McCarthy; Marcelo C Pasquini; Gordon L Phillips; J Douglas Rizzo; Jorge Sierra; Martin S Tallman; Daniel J Weisdorf
Journal:  Blood       Date:  2009-12-23       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.